AzTrials
AzTrials

Amputation, TraumaticNCT05827744

The Relationship Between Thicknesses and Isokinetic Strength of Hip Flexor and Extensor Muscles

An observational study of Amputation, Traumatic, run by Gaziler Physical Medicine and Rehabilitation Education and Research Hospital at 1 site in Turkey (Türkiye).

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of this study is to investigate the relationship of hip muscle thicknesses measured by ultrasonography with hip flexion and extension strength and clinical parameters in prosthesis users with unilateral traumatic transfemoral amputation. Read more about this study

Who is it for?
Ages 18 to 65 years, men only
Conditions the study is for
Amputation, Traumatic
What is being tested?
Isokinetic evaluations and Ultrasonographic evaluations
How many people
27 participants
Where
1 siteTurkey (Türkiye)
Study dates
15 May 2023to 15 Dec 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • Men only
  • No healthy volunteers
  • Adult, Older adult

Study population: A total of 27 patients with unilateral transfemoral amputation

Who may be able to join

  • Aged between 18-65
  • The time elapsed after amputation > 6 months
  • Using prosthesis for at least 3 months
  • Being able to walk without an assistive device

Who cannot join

  • Bilateral lower extremity amputation
  • Presence of neurological, cardiovascular, and pulmonary disease that may affect walking performance

Trial locations and contacts

1 site in 1 country.

Merve Örücü Atar, MD contact

03122912443

drmerveorucu@hotmail.com

Turkey (Türkiye)1 site, 1 recruiting
  • Ankara Gaziler Physical Medicine and Rehabilitation Education and Research Hospital

    Ankara

    Merve Örücü Atar

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: The Evaluation of the Relationship Between Thicknesses and Isokinetic Strength of Hip Flexor and Extensor Muscles in Patients With Unilateral Traumatic Transfemoral Amputation

The aim of this study is to investigate the relationship of hip muscle thicknesses measured by ultrasonography with hip flexion and extension strength and clinical parameters in prosthesis users with unilateral traumatic transfemoral amputation.

Read the detailed description

The aim of this study is to investigate the relationship of hip muscle thicknesses measured by ultrasonography with hip flexion and extension strength and clinical parameters in prosthesis users with unilateral traumatic transfemoral amputation.

This study will be useful in understanding whether ultrasonography is an appropriate imaging method in the follow-up of changes in functional strength in the hip girdle in patients with unilateral traumatic transfemoral amputation.

Being tested
Isokinetic evaluations, Ultrasonographic evaluations
Keywords
amputation, hip flexors, hip extensors
Medical subject headings
Amputation, Traumatic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Isokinetic evaluationsOther

    Peak torque and total amount of work of hip flexors and extensors will be determined by the Cybex 6000 model computer-aided isokinetic system.

  • Ultrasonographic evaluationsOther

    Ultrasonographic evaluations will be performed with a 5-12 MHz linear probe (Logic e portable; GE Healthcare, China). The thicknesses of the hip flexor (psoas major) and extensor (gluteus maximus) muscles will be measured while the patient is in the prone position, in accordance with the literature.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. 6-minute walking test (6MWT)

    Functional performance will be assessed by 6MWT (in meter). Patients will be instructed to walk quickly, safely, and as much distance as possible over a rectangular path.

    Measured: through study completion, an average of one month

  2. 10-meter walking test

    The short-distance over-ground gait speed will be assessed using a 10-Meter Walk Test. Participants will be asked to walk at normal pace on a 10-meter walkway.

    Measured: through study completion, an average of one month

  3. Timed up and go test

    Timed up and go test will be used for quantifying functional mobility balance. Participants will be instructed to sit in a comfortable position on a 45-65 cm high steady chair with a backrest and armrest, with both arms resting on their thighs, and then quickly stand up and move towards and around a fixed cone 3 m away, return, and sit again.

    Measured: through study completion, an average of one month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Apr 2023
  2. Study start15 May 2023
  3. Primary completion15 Dec 2023 (estimated)
  4. Study completion15 Dec 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Cross-sectional
Enrolment
27 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05827744
Sponsor's protocol ID
36
Status last verified
Oct 2023
First submitted
12 Apr 2023
Last updated
23 Oct 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Amputation, Traumatic, run by Gaziler Physical Medicine and Rehabilitation Education and Research Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 23 Oct 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Merve Örücü Atar, MD (03122912443, drmerveorucu@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

6-minute walking test (6MWT) (time frame: through study completion, an average of one month). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Oct 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in